Inside the Gut Health Gold Rush
A clinically-proven gut-health and weight-management player turning a decade of science into sales, in one of health's fastest-growing markets
Bull Case
The Natural Answer to the Ozempic Problem
SlimBiome is clinically proven to reduce hunger and food cravings in four human studies and is positioned as a healthier more sustainable weight management solution
A Decade of Investment, Now Converting to Sales
Heavy spending done, sales rising, margins up, break-even in sight
Untapped Value in Sugar, Microbiome Modulators and Investment Business
Patent-rich sugar substitute and microbiome modulators present potential upside, plus company has valuable stakes in two listed spin-outs
Bear Case
Key Strategic Markets Under-Penetrated
US and India have great potential, but yet to fully deliver and depend on limited number of customers
SweetBiotix Still Has to Deliver on its Potential
Early signs are promising, but full potential depends on launching commercial products
Sub-scale and Tightly Funded
Depressed shares, modest cash, and profitability not yet delivered
CurationAI can make mistakes, this is not investment advice. OptiBiotix Health is a client of Curation.